OralID™ is manufactured by Forward Science, a company that was founded with the vision to create a simpler, efficient, and more affordable oral cancer screening device that can save more lives. OralID uses the same proven fluorescence technology as other oral exam devices, with no up-front costs and lower overall lifetime costs. In addition, unlike any other device on the market, OralID has no per-patient cost during use.
OralID uses a proven, optically based technology called, "fluorescence technology." OralID's fluorescence technology uses a blue light (435–460 nm) that provides the clinician an aid in visualization of oral cancer, pre-cancer and other abnormal lesions. The other medical applications of fluorescence technology include highlighting abnormalities of the GI tract, cervix, lung, and skin.
The CDC recommends the use of a sheath during standard procedures as best practice.